The Traderszone Network

Published in TZ Latest News 11 July, 2016 by The TZ Newswire Staff

CELYAD S.A.: Celyad enters into license agreement with ONO PHARMACEUTICAL CO., LTD. to develop allogeneic NKR-2 T-cell immunotherapy